Reckitt Benckiser Group Plc (LON:RB)’s stock price passed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $6,311.90 and traded as low as $6,079.00. Reckitt Benckiser Group shares last traded at $6,254.00, with a volume of 1,511,626 shares traded.
RB has been the subject of a number of recent analyst reports. Credit Suisse Group set a GBX 5,800 ($75.79) target price on Reckitt Benckiser Group and gave the stock a “sell” rating in a research report on Wednesday, July 31st. Sanford C. Bernstein set a GBX 8,100 ($105.84) target price on Reckitt Benckiser Group and gave the stock a “buy” rating in a research report on Tuesday, July 30th. Barclays set a GBX 7,700 ($100.61) target price on Reckitt Benckiser Group and gave the stock a “buy” rating in a research report on Wednesday, July 31st. Morgan Stanley reaffirmed an “overweight” rating on shares of Reckitt Benckiser Group in a research report on Monday, July 15th. Finally, Jefferies Financial Group set a GBX 5,300 ($69.25) target price on Reckitt Benckiser Group and gave the stock a “sell” rating in a research report on Monday, June 24th. Four investment analysts have rated the stock with a sell rating, three have issued a hold rating and eleven have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of GBX 7,148.33 ($93.41).
The company has a debt-to-equity ratio of 85.08, a current ratio of 0.59 and a quick ratio of 0.43. The firm has a 50 day simple moving average of GBX 6,309.60 and a 200-day simple moving average of GBX 6,228.12. The stock has a market capitalization of $44.34 billion and a price-to-earnings ratio of 31.40.
Reckitt Benckiser Group Company Profile (LON:RB)
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
Featured Story: What are momentum indicators and what do they show?
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.